A controlled study was conducted to evaluate the feasibility of robotic automation of routine regulatory drug dissolution measurements. A commercially available laboratory robot system automated a number of dissolution analyses while concurrent manually acquired samples were analyzed by the same analytical method. The results were subjected to a statistical analysis of variance (ANOVA). After some small sources of systematic bias were eliminated, the results obtained by the robot were statistically indistinguishable from the manual results.